198
Views
2
CrossRef citations to date
0
Altmetric
Review

A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse

ORCID Icon, ORCID Icon & ORCID Icon
Pages 269-282 | Received 14 Feb 2023, Accepted 08 Apr 2023, Published online: 06 May 2023

References

  • Barrientos RM, Brunton PJ, Lenz KM, Pyter L, Spencer SJ. Neuroimmunology of the female brain across the lifespan: plasticity to psychopathology. Brain Behav Immun. 2019;79:39–55. doi:10.1016/j.bbi.2019.03.010.
  • Erickson EK, Grantham EK, Warden AS, Harris RA. Neuroimmune signaling in alcohol use disorder. Pharmacol Biochem Behav. 2019;177:34–60. doi:10.1016/j.pbb.2018.12.007.
  • Lacagnina MJ, Rivera PD, Bilbo SD. Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2017;42:156–77. doi:10.1038/npp.2016.121.
  • Vargas AM, Rivera-Rodriguez DE, Martinez LR. Methamphetamine alters the TLR4 signaling pathway, NF-κB activation, and pro-inflammatory cytokine production in LPS-challenged NR-9460 microglia-like cells. Mol Immunol. 2020;121:159–66. doi:10.1016/j.molimm.2020.03.013.
  • Blanco AM, Vallés SL, Pascual M, Guerri C. Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J Immunol. 2005;175:6893–99. doi:10.4049/jimmunol.175.10.6893.
  • Pascual M, Baliño P, Alfonso-Loeches S, Aragón CM, Guerri C. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav Immun. 2011;25:S80–91. doi:10.1016/j.bbi.2011.02.012.
  • Warden AS, Azzam M, DaCosta A, Mason S, Blednov YA, Messing RO, Mayfield RD, Harris RA. Toll-like receptor 3 dynamics in female C57BL/6J mice: regulation of alcohol intake. Brain Behav Immun. 2019;77:66–76. doi:10.1016/j.bbi.2018.12.006.
  • Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018;35:851–60. doi:10.1002/da.22771.
  • Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405. doi:10.1016/S1474-4422(15)70016-5.
  • Terry-McElrath YM, O’Malley PM, Johnston LD. Alcohol and marijuana use patterns associated with unsafe driving among U.S. high school seniors: high use frequency, concurrent use, and simultaneous use. J Stud Alcohol Drugs. 2014;75:378–89. doi:10.15288/jsad.2014.75.378.
  • Salguero A, Pilatti A, Michelini Y, Rivarola Montejano G, Pautassi RM. Factors associated with simultaneous or concurrent use of alcohol and marijuana in Argentina. Subst use misuse. 2022;57:1062–71. doi:10.1080/10826084.2022.2063895.
  • Jackson KM, Sokolovsky AW, Gunn RL, White HR. Consequences of alcohol and marijuana use among college students: prevalence rates and attributions to substance-specific versus simultaneous use. Psychol Addict Behav. 2020;34:370–81. doi:10.1037/adb0000545.
  • Cruz B, Castañeda K, Aranda M, Hinojosa CA, Castro-Gutierrez R, Flores RJ, Spencer CT, Vozella V, Roberto M, Gadad BS, et al. Alcohol self-administration and nicotine withdrawal alter biomarkers of stress and inflammation and prefrontal cortex changes in Gβ subunits. Am J Drug Alcohol Abuse. 2022;1–12. doi:10.1080/00952990.2022.2121656.
  • Walter KR, Ricketts DK, Presswood BH, Smith SM, Mooney SM. Prenatal alcohol exposure causes persistent microglial activation and age- and sex- specific effects on cognition and metabolic outcomes in an Alzheimer’s disease mouse model. Am J Drug Alcohol Abuse. 2022;1–19. doi:10.1080/00952990.2022.2119571.
  • Mondello JE, Gano A, Vore AS, Deak T. Cues associated with repeated ethanol exposure facilitate the corticosterone response to ethanol and immunological challenges in adult male sprague dawley rats: implications for neuroimmune regulation. Am J Drug Alcohol Abuse. 2023;1–11. doi:10.1080/00952990.2023.2169831.
  • Gano A, Lebonville CL, Becker HC. TLR3 activation with poly I: c exacerbates escalated alcohol consumption in dependent male C57BL/6J mice. Am J Drug Alcohol Abuse. 2022;1–12. doi:10.1080/00952990.2022.2092492.
  • Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Johnson JW, Holloway KN, Berquist MD, Kane CJM, Drew PD. Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation. Am J Drug Alcohol Abuse. 2022;1–14. doi:10.1080/00952990.2022.2128361.
  • Grodin EN, Meredith LR, Burnette EM, Miotto K, Irwin MR, Ray LA. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. Am J Drug Alcohol Abuse. 2022;1–12. doi:10.1080/00952990.2022.2124918.
  • Pérez-Reytor D, Karahanian E. Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment. Am J Drug Alcohol Abuse. 2022;1–7. doi:10.1080/00952990.2022.2114005.
  • McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12–23. doi:10.1016/j.cpr.2017.10.012.
  • Substance Abuse and Mental Health Services Administration OoAS. NSDUH Detailed Tables. 2020. https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables.
  • Becker JB. Sex differences in addiction. Dialogues Clin Neurosci. 2016;18:395–402. doi:10.31887/DCNS.2016.18.4/jbecker.
  • Kuhn C. Emergence of sex differences in the development of substance use and abuse during adolescence. Pharmacol Ther. 2015;153:55–78. doi:10.1016/j.pharmthera.2015.06.003.
  • Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. doi:10.3389/fimmu.2018.02279.
  • Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019;56:308–21. doi:10.1007/s12016-017-8648-x.
  • Hoffman JF, Wright CL, McCarthy MM. A critical period in purkinje cell development is mediated by local estradiol synthesis, disrupted by inflammation, and has enduring consequences only for males. J Neurosci. 2016;36:10039–49. doi:10.1523/JNEUROSCI.1262-16.2016.
  • Taylor PV, Veenema AH, Paul MJ, Bredewold R, Isaacs S, de Vries GJ. Sexually dimorphic effects of a prenatal immune challenge on social play and vasopressin expression in juvenile rats. Biol Sex Differ. 2012;3:15. doi:10.1186/2042-6410-3-15.
  • Lovelock D, Randall P, Voorhies K, Vetreno R, Crews F, Besheer J. Increased alcohol self-administration following repeated toll-like receptor 3 agonist treatment in male and female rats. Pharmacol Biochem Behav. 2022;216:173379. doi:10.1016/j.pbb.2022.173379.
  • Doremus-Fitzwater TL, Gano A, Paniccia JE, Deak T. Male adolescent rats display blunted cytokine responses in the CNS after acute ethanol or lipopolysaccharide exposure. Physiol Behav. 2015;148:131–44. doi:10.1016/j.physbeh.2015.02.032.
  • Vore AS, Doremus-Fitzwater T, Gano A, Deak T. Adolescent ethanol exposure leads to stimulus-specific changes in cytokine reactivity and hypothalamic-pituitary-adrenal axis sensitivity in adulthood. Front Behav Neurosci. 2017;11:78. doi:10.3389/fnbeh.2017.00078.
  • Vore AS, Barney TM, Deak MM, Varlinskaya EI, Deak T. Adolescent intermittent ethanol exposure produces sex-specific changes in BBB permeability: a potential role for VEGFA. Brain Behav Immun. 2022;102:209–23. doi:10.1016/j.bbi.2022.02.030.
  • Vore AS, Barney TM, Gano A, Varlinskaya EI, Deak T. Adolescent intermittent ethanol (AIE) produces sex specific alterations in adult neuroimmune gene expression and ethanol sensitivity that are independent of ethanol metabolism. Neuropharmacology. 2021;195:108635. doi:10.1016/j.neuropharm.2021.108635.
  • Pilatti A, Read JP, Pautassi RM. ELSA 2016 cohort: alcohol, tobacco, and marijuana use and their association with age of drug use onset, risk perception, and social norms in Argentinean college freshmen. Front Psychol. 2017;8:1452. doi:10.3389/fpsyg.2017.01452.
  • Pascual M, Boix J, Felipo V, Guerri C. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J Neurochem. 2009;108:920–31. doi:10.1111/j.1471-4159.2008.05835.x.
  • Fabio MC, Nizhnikov ME, Spear NE, Pautassi RM. Binge ethanol intoxication heightens subsequent ethanol intake in adolescent, but not adult, rats. Dev Psychobiol. 2014;56:574–83. doi:10.1002/dev.21101.
  • Gano A, Prestia L, Middleton FA, Youngentob SL, Ignacio C, Deak T. Gene expression profiling reveals a lingering effect of prenatal alcohol exposure on inflammatory-related genes during adolescence and adulthood. Cytokine. 2020;133:155126. doi:10.1016/j.cyto.2020.155126.
  • Gosdin LK, Deputy NP, Kim SY, Dang EP, Denny CH. Alcohol consumption and binge drinking during pregnancy among adults aged 18-49 years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep. 2022;71:10–13. doi:10.15585/mmwr.mm7101a2.
  • Griciuc A, Tanzi RE. The role of innate immune genes in Alzheimer’s disease. Curr Opin Neurol. 2021;34:228–36. doi:10.1097/WCO.0000000000000911.
  • Borçoi AR, Patti CL, Zanin KA, Hollais AW, Santos-Baldaia R, Ceccon LM, Berro LF, Wuo-Silva R, Grapiglia SB, Ribeiro LT, et al. Effects of prenatal immune activation on amphetamine-induced addictive behaviors: contributions from animal models. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;63:63–69. doi:10.1016/j.pnpbp.2015.05.015.
  • Gano A, Doremus-Fitzwater TL, Deak T. A cross-sectional comparison of ethanol-related cytokine expression in the hippocampus of young and aged Fischer 344 rats. Neurobiol Aging. 2017;54:40–53. doi:10.1016/j.neurobiolaging.2017.01.025.
  • Gano A, Mondello JE, Doremus-Fitzwater TL, Deak T. Rapid alterations in neuroimmune gene expression after acute ethanol: timecourse, sex differences and sensitivity to cranial surgery. J Neuroimmunol. 2019;337:577083. doi:10.1016/j.jneuroim.2019.577083.
  • Suryanarayanan A, Carter JM, Landin JD, Morrow AL, Werner DF, Spigelman I. Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol. Neuropharmacology. 2016;107:181–88. doi:10.1016/j.neuropharm.2016.03.027.
  • Barney TM, Vore AS, Trapp SL, Finkenberg CL, Pugliesi DR, Schmalzle MM, Evans SH, Varlinskaya EI, Deak T. Circulating corticosterone levels mediate the relationship between acute ethanol intoxication and markers of NF-κB activation in male rats. Neuropharmacology. 2022;210:109044. doi:10.1016/j.neuropharm.2022.109044.
  • Dai X, Thavundayil J, Santella S, Gianoulakis C. Response of the HPA-axis to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Psychoneuroendocrinology. 2007;32:293–305. doi:10.1016/j.psyneuen.2007.01.004.
  • Blaine SK, Sinha R. Alcohol, stress, and glucocorticoids: from risk to dependence and relapse in alcohol use disorders. Neuropharmacology. 2017;122:136–47. doi:10.1016/j.neuropharm.2017.01.037.
  • Avila AH, Morgan CA, Bayer BM. Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J Pharmacol Exp Ther. 2003;305:290–97. doi:10.1124/jpet.102.045989.
  • Gano A, Doremus-Fitzwater TL, Deak T. Sustained alterations in neuroimmune gene expression after daily, but not intermittent, alcohol exposure. Brain Res. 2016;1646:62–72. doi:10.1016/j.brainres.2016.05.027.
  • Saunders BT, O’Donnell EG, Aurbach EL, Robinson TE. A cocaine context renews drug seeking preferentially in a subset of individuals. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2014;39:2816–23. doi:10.1038/npp.2014.131.
  • Lebonville CL, Jones ME, Hutson LW, Cooper LB, Fuchs RA, Lysle DT. Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus. Brain Behav Immun. 2016;56:325–34. doi:10.1016/j.bbi.2016.04.005.
  • Hutson LW, Lebonville CL, Jones ME, Fuchs RA, Lysle DT. Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression. Brain Behav Immun. 2017;62:171–79. doi:10.1016/j.bbi.2017.01.017.
  • Gano A, Pautassi RM, Doremus-Fitzwater TL, Deak T. Conditioned effects of ethanol on the immune system. Exp Biol Med. 2017;242:718–30. doi:10.1177/1535370217694097.
  • Gano A, Pautassi RM, Doremus-Fitzwater TL, Barney TM, Vore AS, Deak T. Highlight article: conditioning the neuroimmune response to ethanol using taste and environmental cues in adolescent and adult rats. Exp Biol Med. 2019;244:362–71. doi:10.1177/1535370219831709.
  • Yang T, Zang S, Wang Y, Zhu Y, Jiang L, Chen X, Zhang X, Cheng J, Gao R, Xiao H, et al. Methamphetamine induced neuroinflammation in mouse brain and microglial cell line BV2: roles of the TLR4/TRIF/Peli1 signaling axis. Toxicol Lett. 2020;333:150–58. doi:10.1016/j.toxlet.2020.07.028.
  • Wang X, Loram LC, Ramos K, de Jesus AJ, Thomas J, Cheng K, Reddy A, Somogyi AA, Hutchinson MR, Watkins LR, et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci. 2012;109:6325–30. doi:10.1073/pnas.1200130109.
  • Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J, van Steeg K, Kopajtic TA, Loram LC, Sfregola C, et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci. 2012;32:11187–200. doi:10.1523/JNEUROSCI.0684-12.2012.
  • Periyasamy P, Liao K, Kook YH, Niu F, Callen SE, Guo ML, Buch S. Cocaine-mediated downregulation of miR-124 activates microglia by targeting KLF4 and TLR4 signaling. Mol Neurobiol. 2018;55:3196–210. doi:10.1007/s12035-017-0584-5.
  • Montagud-Romero S, Reguilón MD, Pascual M, Blanco-Gandía MC, Guerri C, Miñarro J, Rodríguez-Arias M. Critical role of TLR4 in uncovering the increased rewarding effects of cocaine and ethanol induced by social defeat in male mice. Neuropharmacology. 2021;182:108368. doi:10.1016/j.neuropharm.2020.108368.
  • Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci. 2010;30:8285–95. doi:10.1523/JNEUROSCI.0976-10.2010.
  • Montesinos J, Pascual M, Pla A, Maldonado C, Rodríguez-Arias M, Miñarro J, Guerri C. TLR4 elimination prevents synaptic and myelin alterations and long-term cognitive dysfunctions in adolescent mice with intermittent ethanol treatment. Brain Behav Immun. 2015;45:233–44. doi:10.1016/j.bbi.2014.11.015.
  • Orio L, Alen F, Pavón FJ, Serrano A, García-Bueno B. Oleoylethanolamide, neuroinflammation, and alcohol abuse. Front Mol Neurosci. 2018;11:490. doi:10.3389/fnmol.2018.00490.
  • Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and epigenetic modifiers of alcoholic liver disease. Int J Mol Sci. 2018;19. doi:10.3390/ijms19123857.
  • Pérez-Rubio G, Córdoba-Lanús E, Cupertino P, Cartujano-Barrera F, Campos MA, Falfán-Valencia R. Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. Rev Invest Clin. 2019;71:36–54. doi:10.24875/RIC.18002617.
  • Scholl JL, King ZR, Pearson K, Kallsen NA, Ehli EA, Fercho KA, Brown-Rice KA, Forster GL, Baugh LA. Methylation of genes and regulation of inflammatory processes on emotional response in young adults with alcoholic parents. Brain Behav Immun - Health. 2022;25:100505. doi:10.1016/j.bbih.2022.100505.
  • Kranzler HR, Zhou H, Kember RL, Vickers Smith R, Justice AC, Damrauer S, Tsao PS, Klarin D, Baras A, Reid J, et al. Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun. 2019;10:1499. doi:10.1038/s41467-019-09480-8.
  • Wiström ED, O’Connell KS, Karadag N, Bahrami S, Hindley GFL, Lin A, Cheng W, Steen NE, Shadrin A, Frei O, et al. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci. Addiction. 2022;117:600–10. doi:10.1111/add.15680.
  • Ramos A, Joshi RS, Szabo G. Innate immune activation: parallels in alcohol use disorder and Alzheimer’s disease. Front Mol Neurosci. 2022;15:910298. doi:10.3389/fnmol.2022.910298.
  • Klostermann K, Chen R, Kelley ML, Schroeder VM, Braitman AL, Mignone T. Coping behavior and depressive symptoms in adult children of alcoholics. Subst use misuse. 2011;46:1162–68. doi:10.3109/10826080903452546.
  • Roy N, Nadda N, Kumar H, Prasad C, Kumar Jha J, Pandey HC, Vanamail P, Saraya A, Balhara YPS, Shalimar, et al. Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility. Front Immunol. 2022;13:975027. doi:10.3389/fimmu.2022.975027.
  • Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients. Alcohol Clin Exp Res. 2013;37:244–51. doi:10.1111/j.1530-0277.2012.01925.x.
  • Marcos M, Pastor I, González-Sarmiento R, Laso FJ. Interleukin-10 gene polymorphism is associated with alcoholism but not with alcoholic liver disease. Alcohol Alcohol. 2008;43:523–28. doi:10.1093/alcalc/agn026.
  • Pastor IJ, Laso FJ, Avila JJ, Rodríguez RE, González-Sarmiento R. Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. Alcohol Clin Exp Res. 2000;24:1479–82. doi:10.1111/j.1530-0277.2000.tb04563.x.
  • Osterndorff-Kahanek E, Ponomarev I, Blednov YA, Harris RA. Gene expression in brain and liver produced by three different regimens of alcohol consumption in mice: comparison with immune activation. PLoS One. 2013;8:e59870. doi:10.1371/journal.pone.0059870.
  • Wilhelm CJ, Fuller BE, Huckans M, Loftis JM. Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory. Drug Alcohol Depend. 2017;176:71–78. doi:10.1016/j.drugalcdep.2017.02.023.
  • Lyall LM, Cullen B, Lyall DM, Leighton SP, Siebert S, Smith DJ, Cavanagh J. The associations between self-reported depression, self-reported chronic inflammatory conditions and cognitive abilities in UK biobank. Eur Psychiatry. 2019;60:63–70. doi:10.1016/j.eurpsy.2019.05.007.
  • Kowalec K, Carney H, Patel M, Hitchon C, Bolton JM, Patten SB, Graff LA, Bernstein CN, Peschken C, Marrie RA. Prevalence and risk factors of substance use disorder in rheumatoid arthritis. ACR Open Rheumatol. 2021;3:889–96. doi:10.1002/acr2.11339.
  • Kaiser AJ, Milich R, Lynam DR, Charnigo RJ. Negative urgency, distress tolerance, and substance abuse among college students. Addict Behav. 2012;37:1075–83. doi:10.1016/j.addbeh.2012.04.017.
  • Adams ZW, Kaiser AJ, Lynam DR, Charnigo RJ, Milich R. Drinking motives as mediators of the impulsivity-substance use relation: pathways for negative urgency, lack of premeditation, and sensation seeking. Addict Behav. 2012;37:848–55. doi:10.1016/j.addbeh.2012.03.016.
  • Suneson K, Ängeby F, Lindahl J, Söderberg G, Tjernberg J, Lindqvist D. Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trial. BMC Psychiatry. 2022;22:801. doi:10.1186/s12888-022-04430-z.
  • Xu D, Zhao M. Theragra chalcogramma hydrolysates, rich of fragment gly-leu-pro-ser-tyr-thr, ameliorate alcohol-induced cognitive impairment via attenuating neuroinflammation and enhancing neuronal plasticity in sprague–dawley rats. J Agric Food Chem. 2022;70:12513–24. doi:10.1021/acs.jafc.2c05163.
  • Villas Boas GR, Paes MM, Cunha MS, Ponsoni LF, Stefanello da Silveira AP, Oesterreich SA. Evaluation of the effect of alpha-tocopherol on anxiety and the neuroinflammatory process during alcohol withdrawal in a model of forced and chronic self-administration of liquid diet containing ethanol: behavioral and neurochemical evidence. Alcohol. 2022;104:31–44. doi:10.1016/j.alcohol.2022.08.002.
  • Israel Y, Quintanilla ME, Ezquer F, Morales P, Santapau D, Berríos-Cárcamo P, Ezquer M, Olivares B, Herrera-Marschitz M. Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: role of neuroinflammation-oxidative stress self-perpetuation. Addict Biol. 2021;26:e12853. doi:10.1111/adb.12853.
  • Hughes JR, Kalman D. Do smokers with alcohol problems have more difficulty quitting? Drug Alcohol Depend. 2006;82:91–102. doi:10.1016/j.drugalcdep.2005.08.018.
  • Gatley JM, Callaghan RC. Chapter 10 - tobacco-related mortality among individuals with alcohol or drug use disorders. In: Preedy V, editor. Neuropathology of drug addictions and substance misuse. San Diego: Academic Press; 2016. pp. 104–14.
  • Health NIo. Monitoring the future report. Ann Arbor: University of Michigan; 2015.
  • Kemppainen H, Hyytiä P, Kiianmaa K. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res. 2009;33:340–49. doi:10.1111/j.1530-0277.2008.00838.x.
  • Blomqvist O, Ericson M, Johnson DH, Engel JA, Söderpalm B. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol. 1996;314:257–67. doi:10.1016/S0014-2999(96)00583-3.
  • Liu L, Hendrickson LM, Guildford MJ, Zhao-Shea R, Gardner PD, Tapper AR. Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward. Biol Psychiatry. 2013;73:738–46. doi:10.1016/j.biopsych.2012.09.019.
  • Leão RM, Cruz FC, Vendruscolo LF, de Guglielmo G, Logrip ML, Planeta CS, Hope BT, Koob GF, George O. Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking. J Neurosci. 2015;35:6241–53. doi:10.1523/JNEUROSCI.3302-14.2015.
  • Waeiss RA, Knight CP, Hauser SR, Pratt LA, McBride WJ, Rodd ZA. Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats. Psychopharmacology. 2019;236:1887–900. doi:10.1007/s00213-019-5174-y.
  • Chandler CM, Maggio SE, Peng H, Nixon K, Bardo MT. Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in sprague-dawley rats. Drug Alcohol Depend. 2020;212:107988. doi:10.1016/j.drugalcdep.2020.107988.
  • Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S. Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. BMC Syst Biol. 2015;9:25. doi:10.1186/s12918-015-0167-x.
  • Log T, Hartz I, Handal M, Tverdal A, Furu K, Skurtveit S. The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults–a population-based cohort study. Pharmacoepidemiol Drug Saf. 2011;20:90–98. doi:10.1002/pds.2066.
  • Kozhimannil KB, Graves AJ, Levy R, Patrick SW. Nonmedical use of prescription opioids among pregnant U.S. women. Women’s Health Issues: Off Publ Jacobs Inst Women’s Health. 2017;27:308–15. doi:10.1016/j.whi.2017.03.001.
  • Hyytiä P, Ingman K, Soini SL, Laitinen JT, Korpi ER. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Naunyn-Schmiedeberg’s Arch Pharmacol. 1999;360:391–401. doi:10.1007/s002109900070.
  • Warden A, Truitt J, Merriman M, Ponomareva O, Jameson K, Ferguson LB, Mayfield RD, Harris RA. Localization of PPAR isotypes in the adult mouse and human brain. Sci Rep. 2016;6:27618. doi:10.1038/srep27618.
  • Ju Z, Su M, Hong J, Kim E, Jung JH. Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition. Bioorg Chem. 2020;96:103611. doi:10.1016/j.bioorg.2020.103611.
  • Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci. 2008;13:1813–26. doi:10.2741/2802.
  • Davis RL, Syapin PJ. Ethanol increases nuclear factor-kappa B activity in human astroglial cells. Neurosci Lett. 2004;371:128–32. doi:10.1016/j.neulet.2004.08.051.
  • Zou J, Crews F. Induction of innate immune gene expression cascades in brain slice cultures by ethanol: key role of NF-κB and proinflammatory cytokines. Alcohol Clin Exp Res. 2010;34:777–89. doi:10.1111/j.1530-0277.2010.01150.x.
  • Edenberg HJ, Xuei X, Wetherill LF, Bierut L, Bucholz K, Dick DM, Hesselbrock V, Kuperman S, Porjesz B, Schuckit MA, et al. Association of NFKB1, which encodes a subunit of the transcription factor NF-kappaB, with alcohol dependence. Hum Mol Genet. 2008;17:963–70. doi:10.1093/hmg/ddm368.
  • Chen YL, Law PY, Loh HH. Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J Neuroimmune Pharmacol. 2006;1:270–79. doi:10.1007/s11481-006-9028-0.
  • Karahanian E, Quintanilla ME, Fernandez K, Israel Y. Fenofibrate–a lipid-lowering drug–reduces voluntary alcohol drinking in rats. Alcohol. 2014;48:665–70. doi:10.1016/j.alcohol.2014.08.004.
  • Stopponi S, de Guglielmo G, Somaini L, Cippitelli A, Cannella N, Kallupi M, Ubaldi M, Heilig M, Demopulos G, Gaitanaris G, et al. Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats. Alcohol Clin Exp Res. 2013;37:1351–60. doi:10.1111/acer.12091.
  • Roman M, Irwin MR. Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far. Brain Behav Immun. 2020;83:7–21. doi:10.1016/j.bbi.2019.09.016.
  • Mizuno T, Kurotani T, Komatsu Y, Kawanokuchi J, Kato H, Mitsuma N, Suzumura A. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology. 2004;46:404–11. doi:10.1016/j.neuropharm.2003.09.009.
  • Johnson K, Matsuda K, Iwaki Y. Ibudilast for the treatment of drug addiction and other neurological conditions. Clin Investig. 2014;4:269–79. doi:10.4155/cli.14.8.
  • Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, et al. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol. 2016;21:895–903. doi:10.1111/adb.12261.
  • Oliveira GB, Fontes Ede A Jr., de Carvalho S, da Silva JB, Fernandes LM, Oliveira MC, Prediger RD, Gomes-Leal W, Lima RR, Maia CS. Minocycline mitigates motor impairments and cortical neuronal loss induced by focal ischemia in rats chronically exposed to ethanol during adolescence. Brain Res. 2014;1561:23–34. doi:10.1016/j.brainres.2014.03.005.
  • Avalos MP, Guzman AS, Rigoni D, Gorostiza EA, Sanchez MA, Mongi-Bragato B, Garcia-Keller C, Perassi EM, Virgolini MB, Peralta Ramos JM, et al. Minocycline prevents chronic restraint stress-induced vulnerability to developing cocaine self-administration and associated glutamatergic mechanisms: a potential role of microglia. Brain Behav Immun. 2022;101:359–76. doi:10.1016/j.bbi.2022.01.014.
  • Ezquer F, Quintanilla ME, Morales P, Santapau D, Munita JM, Moya-Flores F, Ezquer M, Herrera-Marschitz M, Israel Y. A dual treatment blocks alcohol binge-drinking relapse: microbiota as a new player. Drug Alcohol Depend. 2022;236:109466. doi:10.1016/j.drugalcdep.2022.109466.
  • Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, Ribeiro EA, Russo SJ, Nestler EJ. Alterations of the host microbiome affect behavioral responses to cocaine. Sci Rep. 2016;6:35455. doi:10.1038/srep35455.
  • Bajaj JS, Gavis EA, Fagan A, Wade JB, Thacker LR, Fuchs M, Patel S, Davis B, Meador J, Puri P, et al. A randomized clinical trial of fecal microbiota transplant for alcohol use disorder. Hepatology. 2021;73:1688–700. doi:10.1002/hep.31496.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.